$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
TAPS is a chronic form of feto-fetal transfusion syndrome and characterized by a large inter-twin hemoglobin (Hb) difference without signs of oligo-polyhydramnios sequences1. The main pathogenesis of TAPS is related to the unique placental angioarchitecture, with only a few minuscule anastomoses allowing for chronic and low velocity transfusion from the donor (anemic twin) to recipient (polycythemic twin)2,3,4. Postnatal diagnosis of TAPS is based on hematological tests showing a large Hb difference and large reticulocyte count difference and/or placental injection with dye showing only minuscule anastomoses5. However, reticulocyte count is not always measured at birth, and placental injection is not routinely performed in most fetal medicine centers. An additional diagnostic criterion may be useful to help diagnose cases without reticulocyte count measurements and without placental dye injection. A striking color difference between the pale skin of a donor twin and the plethoric skin of the recipient twin is consistently present in TAPS twins at birth. A similar color difference of the maternal side between placental territories of the anemic and polycythemic twins is also detected upon gross examination.
It has been recently hypothesized that this placental color difference may be used as a simple and accurate method to confirm a TAPS diagnosis after birth6. The quantification of color difference in TAPS placentas is timesaving compared to placental injection. Additionally, quantification of color difference in TAPS placentas is more cost-effective compared to reticulocyte count. The materials used in this method are easily available in clinical settings Therefore, this method provides simple and accurate criteria for the diagnosis of TAPS. The protocol describes a detailed method for the quantification of color differences from the maternal side of monochorionic placentas with TAPS.